COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,786 Articles (22,946 medRxiv, 8,840 bioRxiv)

Most recent first Previous |  Page 2023: Articles 20221-20230  | Next

Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia.
MacIntyre, C. R., Costantino, V., Trent, M. J.
10.1101/2020.12.15.20248278 — Posted: 2020-12-18
Fundamental Limitations of Contact Tracing for COVID-19
Tupper, P. F., Otto, S., Colijn, C.
10.1101/2020.12.15.20248299 — Posted: 2020-12-18
Genomic and phylogenetic analyses of SARS-CoV-2 strains isolated in the city of Gwangju, South Korea
Min Ji, K., Ji-eun, L., Jae Keun, C., Tae sun, K., Jungwook, P., Mi hyeon, L., Da jeong, H., Jin, J., Ji-eun, Y., Hye young, K., Jin jong, S., Kwang gon, K.
10.1101/2020.12.16.423178 — Posted: 2020-12-18
A human coronavirus evolves antigenically to escape antibody immunity
Eguia, R., Crawford, K. H. D., Stevens-Ayers, T., Kelnhofer-Millevolte, L., Greninger, A. L., Englund, J. A., Boeckh, M. J., Bloom, J. D.
10.1101/2020.12.17.423313 — Posted: 2020-12-18 Discussion: Offsite
Molecular diversity analysis of the spike glycoprotein (S) gene from Hong Kong - China
Da Silva, E. D. A. B., Venancio, D. B. R., Albuquerque, R. M. d., Ramos, R. d. S., Felix, P. T.
10.1101/2020.12.16.423166 — Posted: 2020-12-17
Suppression of miR-155 attenuates lung cytokine storm induced by SARS-CoV-2 infection in human ACE2-transgenic mice
Soni, D. K., Cabrera-Luque, J., Kar, S., Sen, C., Devaney, J., Biswas, R.
10.1101/2020.12.17.423130 — Posted: 2020-12-17
Modelling conformational state dynamics and its role on infection for SARS-CoV-2 Spike protein variants
Teruel, N., Mailhot, O., Najmanovich, R.
10.1101/2020.12.16.423118 — Posted: 2020-12-17
Physiological Effects of Exercising at Different Intensities Wearing TNT or Double-layer Cotton Facemasks Compared to Not Wearing a Mask
Braga, F., Espinosa, G., Monteiro, A., Marinho, B., Drummond, E.
10.1101/2020.12.11.20203224 — Posted: 2020-12-17
Influence of clinical characteristics and anti-cancer therapy on outcomes from SARS-CoV-2 infection: a systematic review and meta-analysis of 5,678 cancer patients
Chin, I. S., Galavotti, S., Yip, K. P., Curley, H., Arnold, R., Sharma-Oates, A., Chegwidden, L., Lee, S. I., Lee, L. Y., Pinato, D. J., Dettorre, G. M., Palles, C.
10.1101/2020.12.15.20248195 — Posted: 2020-12-17
Quantifying the importance and location of SARS-CoV-2 transmission events in large metropolitan areas
Aleta, A., Martin-Corral, D., Bakker, M., Pastore y Piontti, A., Ajelli, M., Litvinova, M., Chinazzi, M., Dean, N. E., Halloran, M. E., Longini, I. M., Pentland, A., Vespignani, A., Moreno, Y., Moro, E.
10.1101/2020.12.15.20248273 — Posted: 2020-12-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).